Featured Stories
Medis Proudly Announces a New Partnership with Biocodex Nordics
Exclusive distribution agreement for Medis’ latest development Ladiva, which will be commercialized by Biocodex Nordics in Finland, represents a new important...
Read MoreA new partnership with Neurim Pharmaceuticals Ltd.
Our exclusive distribution agreement for the commercialization of Slenyto® represents an important milestone for both companies.
Read MorePeriodontitis – A War on Teeth and Immune System
The known disease of periodontal tissue does not only cause loss of teeth, but impacts the immune system as well.
Read MoreDo not let the statistics bury hope!
What kind of a mark does cancer leave on men and what is the role of their women when facing the disease? Why are oncological diseases still stigmatized and why...
Read MoreABC of tooth brushing
Care for health and good well-being includes also healthy teeth and gums. Today is the World Oral Health Day and this is why we are sharing with you advice on...
Read MoreInternational rare disease day
At Medis we define the International Rare Disease Day as a commitment to bring novelty therapies to our patients and to help patient organizations with rare...
Read More